Clinical Trial Update: Extracorporeal Shockwave Therapy for the Treatment of Refractory Chronic Angina Pectoris [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating Extracorporeal Shockwave Therapy for refractory chronic angina pectoris. The study is sponsored by Medispec.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris

Drugs mentioned

• Extracorporeal shockwave therapy (Shockwave therapy)

Snippet

Sponsor: Medispec | Conditions: Refractory Angina Pectoris | Phase 1 | Status: UNKNOWN